MedPath

Vibration Training in Chronic Obstructive Pulmonary Disease (COPD)-Patients During a Three-week Rehabilitation

Not Applicable
Completed
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Procedure: whole body vibration training
Registration Number
NCT01380652
Lead Sponsor
Schön Klinik Berchtesgadener Land
Brief Summary

The aim of this study is to investigate the change of physical activity in COPD-patients performing a whole body vibration training additional to a standard three-week rehabilitation program in comparison to patients performing merely a standard rehabilitation program.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  • Chronic obstructive pulmonary disease III/IV
Exclusion Criteria
  • Severe exacerbations in the last 4 weeks prior to begin of study (definition of exacerbation: symptoms on more than 3 days with a relevant change in drug therapy (cortisone, antibiotics))
  • Severe disease other than COPD, that could influence the results of the study
  • Abuse of alcohol or drugs
  • Simultaneously participation in another study
  • Tachypnea (>30/min)
  • Severe exacerbation during rehabilitation
  • Cardiac insufficiency (NYHA IV)
  • Myocardial infarction during the last 6 weeks
  • Mental-health problem
  • Pregnancy
  • Known HIV-infection
  • Slipped disk
  • Acute discopathy
  • Acute thrombosis
  • Implants in trained regions of the body (lower extremities)
  • Acute inflammation of the locomotor system, active arthrosis or rheumatoid arthritis
  • Acute tendinopathy in trained regions of the body
  • Acute hernia
  • Fresh fractures, wounds or scars in trained regions of the body
  • Gallstones or stones in the urinary tract collection system

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
rehabilitation with vibration trainingwhole body vibration training-
Primary Outcome Measures
NameTimeMethod
Activityday 2 and 17

change in activity from baseline to day 17

Secondary Outcome Measures
NameTimeMethod
BODE-Scoreday 1 and 19

Changes in Bode-Score from baseline to day 19

Diffusion Capacityday 1
lung functionday 1

Trial Locations

Locations (1)

Klinikum Berchtesgadener Land, Schön Kliniken

🇩🇪

Schönau am Königssee, Germany

© Copyright 2025. All Rights Reserved by MedPath